Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
Journal website https://www.journalmc.org |
Case Report
Volume 14, Number 6, June 2023, pages 185-190
Unique Variant of Zieve Syndrome With a Normal Reticulocyte Count
Tables
Labs | Value (unit) | Reference range |
---|---|---|
White blood cell | 4.4 × 103/µL | 4.5 - 11.0 × 103/µL |
Red blood cell | 2.85 × 106/µL | 4.10 - 5.10 × 106/µL |
Hemoglobin | 10.2 g/dL | 12 - 16 g/dL |
Platelet count | 110 × 103/µL | 140 - 450 × 103/µL |
Total bilirubin | 16.9 mg/dL | 0.2 - 1.3 mg/dL |
Direct bilirubin | 12.8 mg/dL | 0.0 - 0.3 mg/dL |
Alkaline phosphatase | 287 U/L | 46 - 116 U/L |
Aspartate aminotransferase | 333 U/L | 0 - 34 U/L |
Alanine transaminase | 25 U/L | 10 - 49 U/L |
Reticulocyte count | 2.06% | 0.40-2.50% |
Haptoglobin | 1 mg/dL | 40 - 280 mg/dL |
Lactate dehydrogenase | 326 U/L | 120 - 246 U/L |
Ferritin | 2,718.3 ng/mL | 7.3 - 270.7 ng/mL |
Iron | 85 µg/dL | 50 - 170 µg/dL |
Total iron binding capacity | 157 µg/dL | 250 - 425 µg/dL |
Transferrin | 68 mg/dL | 250 - 380 mg/dL |
Thyroid-stimulating hormone | 39.660 µIU/mL | 0.550 - 4.780 µIU/mL |
Gamma glutamyl transpeptidase | 461 U/L | < 38 U/L |
Immunoglobulin A | 560 mg/dL | 40 - 350 mg/dL |
Ammonia | 76 µmol/L | 11 - 32 µmol/L |
Cholesterol | 232 mg/dL | < 200 mg/dL |
Triglycerides | 249 mg/dL | 0 - 150 mg/dL |
High-density lipoprotein | < 20 mg/dL | 40 - 60 mg/dL |
Low-density lipoprotein | 134 mg/dL | < 100 mg/dL |
Hospital day | Hemoglobin value (reference range 12 - 16 g/dL) |
---|---|
1 | 10.2 g/dL |
2 | 8.5 g/dL |
3 | 7.9 g/dL |
Labs | Value | Reference range |
---|---|---|
Total bilirubin | 4.1 mg/dL | 0.2 - 1.3 mg/dL |
White blood cell | 9.8 × 103/µL | 4.5 - 11.0 × 103/µL |
Hemoglobin | 12.6 g/dL | 12 - 16 g/dL |
Platelet count | 188 × 103/µL | 140 - 450 × 103/µL |
Study | Age (years old) | Sex | Abdominal pain present? | Initial triglyceride levels (mg/dL) | Initial hemoglobin level (g/dL) | Initial reticulocyte count (%) | Initial total bilirubin level (mg/dL) | Initial direct bilirubin level (mg/dL) | Alive at discharge? |
---|---|---|---|---|---|---|---|---|---|
N/A: not available. | |||||||||
Gitlin, 1969 [23] | 48 | Male | Yes | 441 | 12.5 | 5.0 | 10.0 | 9.0 | Yes |
Benraad et al, 1977 [24] | 28 | Male | Yes | 137.4 | 8.7 | 3.7 | 1.2 | 0.2 | Yes |
31 | Male | Yes | 130.0 | 7.9 | 5.8 | 1.6 | 0.5 | Yes | |
50 | Male | Yes | 3.85 | 8.0 | 5.1 | 1.8 | 1.0 | Yes | |
33 | Female | Yes | 3.03 | 8.1 | 13.5 | 0.9 | 0.4 | Yes | |
56 | Female | No | 3.27 | 8.7 | 14.0 | 25.2 | 20.4 | Yes | |
49 | Female | Yes | 327 | 6.3 | 21.0 | 5.0 | 3.0 | Yes | |
41 | Male | Yes | 3.4 | 8.2 | 12.2 | 2.3 | 1.1 | Yes | |
41 | Male | No | 4.14 | 7.3 | 13.2 | 3.2 | 1.8 | Yes | |
63 | Male | No | N/A | 7.4 | 5.55 | 13.5 | 8.8 | Yes | |
65 | Male | No | 4.71 | 8.0 | 20.0 | 13.1 | 10.4 | Yes | |
43 | Male | No | 34.7 | 6.8 | 5.4 | 2.1 | 1.3 | Yes | |
30 | Female | No | 4.05 | 6.8 | 8.1 | 3.6 | 2.2 | Yes | |
31 | Female | No | 2.7 | 6.6 | 8.3 | 2.2 | 1.1 | Yes | |
32 | Female | Yes | 4.0 | 5.8 | 12.6 | 1.7 | 0.7 | Yes | |
29 | Male | Yes | 10.7 | 7.7 | 7.6 | 1.8 | 0.9 | Yes | |
Pickens et al, 1979 [25] | 66 | Female | No | 168.3 | 5.7 | 11.5 | 16.08 | N/A | No |
Martin et al, 1996 [26] | 59 | Female | Yes | 1,700.5 | 8.8 | 5.8 | 2.4 | N/A | Yes |
Pilcher et al, 1996 [27] | 39 | Male | Yes | 11,425.5 | 13.2 | N/A | 1.0 | N/A | Yes |
Piccini et al, 2003 [3] | 47 | Female | Yes | N/A | 7.7 | 3.5 | 4.2 | 2.3 | Yes |
Hashmi et al, 2014 [16] | 30 | Female | No | 578.0 | 10.6 | 8.1 | 38.0 | 26.0 | Yes |
Shukla et al, 2015 [11] | 45 | Male | No | N/A | 6.5 | N/A | 16.0 | 6.3 | Yes |
Senatore et al, 2016 [19] | 32 | Male | Yes | 464 | 8.5 | N/A | 20.0 | 13.0 | Yes |
Liu et al, 2017 [22] | 30 | Female | No | 311.9 | 7.7 | 6.1 | 21.3 | 13.5 | Yes |
Gremida et al, 2018 [1] | 46 | Female | Yes | 208.0 | 7.1 | 11.0 | 12.0 | 2.0 | Yes |
Abughanimeh et al, 2019 [28] | 58 | Male | Yes | N/A | 5.5 | 16.2 | 4.0 | N/A | No |
Choudhry et al, 2019 [8] | 46 | Male | Yes | 4,425.0 | 12.6 | 6.2 | 2.9 | 2.0 | Yes |
Achufusi et al, 2020 [29] | 31 | Female | No | 8,890.0 | 8.1 | N/A | 19.1 | 8.7 | Yes |
Gosal et al, 2021 [30] | 38 | Female | Yes | 172.0 | 6.9 | 5.7 | 11.2 | 2.0 | Yes |
Sams et al, 2022 [17] | 30 | Male | Yes | 5,679.0 | 12.5 | N/A | 2.1 | N/A | Yes |
Sivanandam et al, 2022 [31] | 42 | Male | No | 215.0 | 8.4 | N/A | 10.9 | 4.4 | Yes |
Age | Sex | Abdominal pain present? | Initial triglyceride levels | Initial hemoglobin level | Initial reticulocyte count | Initial total bilirubin level | Initial direct bilirubin level | Alive at discharge? | |
---|---|---|---|---|---|---|---|---|---|
Average | 42.2 years old | 54.8% male | 58.1% | 822.5 mg/dL | 8.2 g/dL | 9.4% | 8.7 mg/dL | 5.5 mg/dL | 93.5% |